Search Results

Trabectedin: an anticancer drug from the sea

Authors: Ganjoo, Kristen N; Patel, SR

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 16, November 2009 , pp. 2735-2743(9)

Publisher: Informa Healthcare

Trabectedin

Authors: Dubois, Eline A.; Cohen, Adam F.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 3, September 2009 , pp. 320-321(2)

Publisher: Blackwell Publishing

Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series

Authors: Grosso, F.; Sanfilippo, R.; Virdis, E.; Piovesan, C.; Collini, P.; Dileo, P.; Morosi, C.; Tercero, J. C.; Jimeno, J.; D'Incalci, M.; Gronchi, A.; Pilotti, S.; Casali, P. G.

Source: Annals of Oncology, Volume 20, Number 8, 22 August 2009 , pp. 1439-1444(6)

Publisher: Oxford University Press

Trabectedin for the management of soft-tissue sarcoma

Authors: Boudou, Laurence; Baconnier, Mathieu; Blay, Jean-Yves; Lombard-Bohas, Catherine; Cassier, Philippe A

Source: Expert Review of Anticancer Therapy, Volume 9, Number 6, June 2009 , pp. 727-737(11)

Publisher: Expert Reviews

Trabectedin: Fatal rhabdomyolysis: case report

Source: Reactions, Volume 1, Number 1254, 2009-05-30 , pp. 40-40(1)

Publisher: Adis International

Trabectedin: Hepatotoxicity, treated with acetylcysteine: case report

Source: Reactions, Volume 1, Number 1243, 2009-03-14 , pp. 43-43(1)

Publisher: Adis International

Evaluation of Human Plasma Protein Binding of Trabectedin (Yondelis™, ET-743)

Authors: Beumer, Jan H.; Lopez-Lazaro, L.; Schellens, Jan H.M.; Beijnen, Jos H.; Tellingen, Olaf v.a.n.

Source: Current Clinical Pharmacology, Volume 4, Number 1, January 2009 , pp. 38-42(5)

Publisher: Bentham Science Publishers

Marine Metabolites Overcoming or Circumventing Multidrug Resistance Mediated by ATP-Dependent Transporters: A New Hope for Patient with Tumors Resistant to Conventional Chemotherapy

Authors: Barthomeuf, Chantal; Bourguet-Kondracki, Marie-Lise; Kornprobst, Jean-Michel

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 8, Number 8, December 2008 , pp. 886-903(18)

Publisher: Bentham Science Publishers

Trabectedin triumphs in ovarian cancer

Source: Inpharma, Volume 1, Number 1657, 2008-09-27 , pp. 11-11(1)

Publisher: Adis International

Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma

Authors: Schöffski, Patrick; Dumez, Herlinde; Wolter, Pascal; Stefan, Cristiana; Wozniak, Agnieszka; Jimeno, Jose; Van Oosterom, Allan T

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 9, June 2008 , pp. 1609-1618(10)

Publisher: Informa Healthcare

Potential Combination Chemotherapy Approaches for Advanced Adult-Type Soft-Tissue Sarcoma

Authors: Kopp, Hans-Georg; Patel, Shreyaskumar; Brücher, Björn; Jörg Thomas Hartmann,

Source: American Journal of Clinical Dermatology, Volume 9, Number 4, 2008 , pp. 207-217(11)

Publisher: Adis International

Semimechanistic pharmacokinetic/pharmacodynamic model for hepatoprotective effect of dexamethasone on transient transaminitis after trabectedin (ET-743) treatment

Authors: Fetterly, Gerald; Owen, Joel; Stuyckens, Kim; Passarell, Julie; Zannikos, Peter; Soto-Matos, Arturo; Izquierdo, Miguel; Perez-Ruixo, Juan

Source: Cancer Chemotherapy and Pharmacology, Volume 62, Number 1, June 2008 , pp. 135-147(13)

Publisher: Springer

Trabectedin showed potential as a single-agent therapy for advanced, recurrent, platinum-sensitive ovarian cancer

Source: Inpharma, Volume 1, Number 1623, 2008-02-02 , pp. 8-8(1)

Publisher: Adis International

Trabectedin (ET-743): evaluation of its use in advanced soft-tissue sarcoma

Authors: Schöffski, Patrick; Wolter, Pascal; Clement, Paul; Sciot, Raf; De Wever, Ivo; Wozniak, Agnieszka; Stefan, Cristiana; Dumez, Herlinde

Source: Future Oncology, Volume 3, Number 4, August 2007 , pp. 381-392(12)

Publisher: Future Medicine

Dynamics of cell cycle phase perturbations by trabectedin (ET-743) in nucleotide excision repair (NER)-deficient and NER-proficient cells, unravelled by a novel mathematical simulation approach

Authors: Tavecchio, M.; Natoli, C.; Ubezio, P.; Erba, E.; D'Incalci, M.

Source: Cell Proliferation, Volume 40, Number 6, December 2007 , pp. 885-904(20)

Publisher: Blackwell Publishing

Product launches in Europe

Source: Inpharma, Volume 1, Number 1611, 2007-10-27 , pp. 22-22(1)

Publisher: Adis International

Trabectedin may be a trump card for sarcoma

Source: Inpharma, Volume 1, Number 1608, 2007-10-06 , pp. 14-14(1)

Publisher: Adis International

Trabectedin: A Review of its Use in the Management of Soft Tissue Sarcoma and Ovarian Cancer

Authors: Carter, Natalie J.; Keam, Susan J.

Source: Drugs, Volume 67, Number 15, 2007 , pp. 2257-2276(20)

Publisher: Adis International

Editorial [Hot Topic: Target Specificity of Effective Anticancer Therapeutics (Executive Editor: G. Capranico)]

Author: Capranico, Giovanni

Source: Current Pharmaceutical Design, Volume 13, Number 27, September 2007 , pp. 2742-2743(2)

Publisher: Bentham Science Publishers

Modulation of Gene Transcription by Natural Products - A Viable Anticancer Strategy

Authors: D'Incalci, M.; Brunelli, D.; Marangon, E.; Simone, M.; Tavecchio, M.; Gescher, A.; Mantovani, R.

Source: Current Pharmaceutical Design, Volume 13, Number 27, September 2007 , pp. 2744-2750(7)

Publisher: Bentham Science Publishers